Kelly Lawrence W & Associates Inc Danaher Corp Transaction History

Kelly Lawrence W & Associates Inc

  • $430 Million
  • Q3 2024

A detailed history of Kelly Lawrence W & Associates Inc transactions in Danaher Corp stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 51,417 shares of DHR stock, worth $11.9 Million. This represents 3.32% of its overall portfolio holdings.

Number of Shares
51,417
Previous 51,918 0.96%
Holding current value
$11.9 Million
Previous $13 Million 10.19%
% of portfolio
3.32%
Previous 3.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$239.25 - $280.76 $119,864 - $140,660
-501 Reduced 0.96%
51,417 $14.3 Million
Q2 2024

Aug 13, 2024
SELL
$235.51 - $267.98 $16,485 - $18,758
-70 Reduced 0.13%
51,918 $13 Million
Q1 2024

May 15, 2024
SELL
$224.58 - $256.19 $279,602 - $318,956
-1,245 Reduced 2.34%
51,988 $13 Million
Q4 2023

Feb 14, 2024
SELL
$185.1 - $233.13 $18,510 - $23,313
-100 Reduced 0.19%
53,233 $12.3 Million
Q3 2023

Nov 14, 2023
BUY
$233.08 - $265.59 $81,578 - $92,956
350 Added 0.66%
53,333 $13.2 Million
Q2 2023

Aug 14, 2023
SELL
$224.99 - $256.14 $258,738 - $294,561
-1,150 Reduced 2.12%
52,983 $12.7 Million
Q1 2023

May 15, 2023
SELL
$239.75 - $277.0 $63,533 - $73,405
-265 Reduced 0.49%
54,133 $13.6 Million
Q4 2022

Feb 14, 2023
SELL
$241.42 - $282.29 $742,366 - $868,041
-3,075 Reduced 5.35%
54,398 $14.4 Million
Q3 2022

Nov 15, 2022
BUY
$247.06 - $1507.4 $217,412 - $1.33 Million
880 Added 1.55%
57,473 $14.8 Million
Q2 2022

Aug 15, 2022
SELL
$237.11 - $299.66 $1.46 Million - $1.85 Million
-6,160 Reduced 9.82%
56,593 $14.3 Million
Q1 2022

May 16, 2022
SELL
$257.27 - $315.76 $1.55 Million - $1.9 Million
-6,015 Reduced 8.75%
62,753 $18.4 Million
Q4 2021

Feb 11, 2022
SELL
$292.08 - $329.01 $372,402 - $419,487
-1,275 Reduced 1.82%
68,768 $22.6 Million
Q3 2021

Nov 15, 2021
SELL
$272.21 - $332.43 $191,908 - $234,363
-705 Reduced 1.0%
70,043 $21.3 Million
Q2 2021

Aug 16, 2021
SELL
$225.08 - $271.69 $225,080 - $271,690
-1,000 Reduced 1.39%
70,748 $19 Million
Q1 2021

May 17, 2021
BUY
$212.38 - $245.9 $4.45 Million - $5.15 Million
20,935 Added 41.2%
71,748 $16.1 Million
Q4 2020

Feb 12, 2021
SELL
$212.5 - $245.46 $6.63 Million - $7.65 Million
-31,185 Reduced 38.03%
50,813 $11.3 Million
Q3 2020

Nov 13, 2020
SELL
$177.16 - $215.33 $8.82 Million - $10.7 Million
-49,760 Reduced 37.77%
81,998 $17.7 Million
Q2 2020

Aug 14, 2020
SELL
$128.7 - $176.83 $82,368 - $113,171
-640 Reduced 0.48%
131,758 $23.3 Million
Q1 2020

May 14, 2020
SELL
$121.39 - $169.05 $2.21 Million - $3.07 Million
-18,170 Reduced 12.07%
132,398 $18.3 Million
Q4 2019

Feb 14, 2020
SELL
$133.47 - $153.48 $162,166 - $186,478
-1,215 Reduced 0.8%
150,568 $23.1 Million
Q3 2019

Nov 14, 2019
SELL
$135.4 - $146.47 $155,710 - $168,440
-1,150 Reduced 0.75%
151,783 $21.9 Million
Q2 2019

Aug 14, 2019
SELL
$124.88 - $143.73 $142,363 - $163,852
-1,140 Reduced 0.74%
152,933 $21.9 Million
Q1 2019

May 15, 2019
SELL
$97.62 - $132.29 $7,321 - $9,921
-75 Reduced 0.05%
154,073 $20.3 Million
Q4 2018

Feb 14, 2019
SELL
$94.85 - $109.54 $81,760 - $94,423
-862 Reduced 0.56%
154,148 $15.9 Million
Q3 2018

Nov 14, 2018
BUY
$98.13 - $108.9 $39,252 - $43,560
400 Added 0.26%
155,010 $16.8 Million
Q2 2018

Aug 14, 2018
BUY
$96.1 - $103.24 $132,137 - $141,955
1,375 Added 0.9%
154,610 $15.3 Million
Q1 2018

May 15, 2018
BUY
$92.16 - $103.8 $14.1 Million - $15.9 Million
153,235 New
153,235 $15 Million

Others Institutions Holding DHR

# of Institutions
2,511
Shares Held
540M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Kelly Lawrence W & Associates Inc Portfolio

Follow Kelly Lawrence W & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email